1. Metabolic Enzyme/Protease Apoptosis Epigenetics Cell Cycle/DNA Damage
  2. Cathepsin Apoptosis PARP Caspase
  3. Cathepsin-IN-5

Cathepsin-IN-5 is a cathepsin inhibitor with IC50 values of 6.2 μM and 81 nM for cathepsin L and cathepsin S. Cathepsin-IN-5 inhibits cancer cells proliferation, induces apoptosis, reduces growth of hepatocellular tumors in mouse models, and modulates expression of genes linked to cell death, cell proliferation, and cellular processes. Cathepsin-IN-5 can be used for the research of hepatocellular carcinoma.

For research use only. We do not sell to patients.

Cathepsin-IN-5

Cathepsin-IN-5 Chemical Structure

CAS No. : 2475078-38-5

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Cathepsin-IN-5 is a cathepsin inhibitor with IC50 values of 6.2 μM and 81 nM for cathepsin L and cathepsin S. Cathepsin-IN-5 inhibits cancer cells proliferation, induces apoptosis, reduces growth of hepatocellular tumors in mouse models, and modulates expression of genes linked to cell death, cell proliferation, and cellular processes. Cathepsin-IN-5 can be used for the research of hepatocellular carcinoma[1].

IC50 & Target[1]

cathepsin S

81 nM (IC50)

cathepsin L

6.2 μM (IC50)

PARP1

 

Caspase 3

 

Cellular Effect
Cell Line Type Value Description References
HepG2 CC50
5.17 μM
Compound: 1
Cytotoxicity against human HepG2 cells assessed as cell growth measured after 72 hrs mby MTT assay
Cytotoxicity against human HepG2 cells assessed as cell growth measured after 72 hrs mby MTT assay
[PMID: 37984297]
In Vitro

Cathepsin-IN-5 (Compound 1) (0.15-300 μM; 24-72 h) exhibits time-dependent antiproliferative activity against Hep G2 and Hep 3B hepatocellular carcinoma cell lines, with IC50 values ranging from 1.8 to 6.4 μM[1].
Cathepsin-IN-5 (7.5-10 μM; 72-96 h) inhibits Hep G2 cell motility and proliferation in a wound healing assay[1].
Cathepsin-IN-5 (0.1-50 μM; 2-24 h) inhibits endogenous cathepsin L (IC50 = 6.2 μM) and cathepsin S (IC50 = 81 nM) activity in Hep G2 cell lysates in a concentration- and time-dependent manner[1].
Cathepsin-IN-5 (0.1-50 μM; 2.5-24 h) does not induce significant intracellular ROS production in Hep G2 or Hep 3B cells[1].
Cathepsin-IN-5 (5-20 μM; 1-24 h) induces concentration- and time-dependent changes in gene expression in Hep G2 cells, enriching pathways related to macroautophagy, apoptosis, and cell migration[1].
Cathepsin-IN-5 (5-20 μM; 6-24 h) significantly upregulates expression of sqstm1, gabarapl1, akr1c1, and akap12 in Hep G2 cells[1].
Cathepsin-IN-5 (5-20 μM; 6-24 h) activates apoptosis in Hep G2 cells in a concentration- and time-dependent manner, increasing cleaved PARP1 and cleaved caspase-3 levels[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: Hep G2
Concentration: 5, 20 μM
Incubation Time: 6 h; 24 h
Result: Significantly upregulated sqstm1, gabarapl1, and akr1c1 expression at 5 μM and 20 μM after 6 h.
Significantly upregulated sqstm1, gabarapl1, akr1c1, and akap12 expression at 20 μM after 24 h.
Modestly decreased angptl8 expression at 20 μM after 24 h.

Western Blot Analysis[1]

Cell Line: Hep G2
Concentration: 5, 20 μM
Incubation Time: 6 h; 24 h
Result: Increased cleaved PARP1 levels at 20 μM after 6 h and 24 h.
Increased cleaved caspase-3 levels at 5 μM and 20 μM after 6 h and 24 h.
Showed concentration- and time-dependent increases in cleaved PARP1 and cleaved caspase-3 levels.
In Vivo

Cathepsin-IN-5 (Compound 1) (100-150 mg/kg; s.c.; daily; 15 days) suppresses subcutaneous HCC xenograft growth in nude mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Foxn1nu (immunocompromised, subcutaneous Hep 3B2.1−7 xenograft model)[1]
Dosage: 100 mg/kg; 150 mg/kg
Administration: s.c.; daily; 15 days (administered proximal to the tumor)
Result: Resulted in a tumor volume fold increase of ~1 (100 mg/kg) and ~2 (150 mg/kg), compared to ~7 in vehicle-treated mice.
Did not significantly elevate plasma AST and ALT levels relative to vehicle-treated mice.
Showed no significant difference in BUN and creatinine levels from vehicle controls.
Showed no signs of systemic toxicity (e.g., lethargy, weight loss).
Molecular Weight

440.47

Formula

C22H20N2O6S

CAS No.
SMILES

O=C(C1=CC=C([N+]([O-])=O)O1)N[C@@H](CCC2=CC=CC=C2)/C=C/S(=O)(C3=CC=CC=C3)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Cathepsin-IN-5
Cat. No.:
HY-182269
Quantity:
MCE Japan Authorized Agent: